Share this article
Share this article
MY01 provides the necessary immediate and timely information (1) to aid physicians in monitoring patients at-risk of developing Compartment Syndrome.(2)
MONTREAL, May 6, 2021 /PRNewswire/ - MY01 Inc. is on a mission to empower healthcare professionals with the ability to pre-empt severe medical conditions, improving patient outcomes. MY01 inc. today announced U.S. Food and Drug Administration 510(k) clearance for the MY01 Continuous Compartment Pressure Monitor with full Bluetooth capabilities.
MY01 s Continuous Compartment Pressure Monitor uses a proprietary and innovative technology to deliver a highly reliable, accurate continuous pressure microsensor directly within the muscle.(2)
The
is a sterile, single-use device. The easy-to-use nature of the MY01 device allows organizations to allocate their healthcare resources to focus on more important activities. Only the MY01 device provides quick, reliable and continuous pressure